OWL awarded Phase 1 SBIR Grant

Orthopedic Wellness Laboratories, Inc. (OWL), a Washington State corporation, has been awarded Phase 1 NIH grant through the highly competitive SBIR process. Grant Number: 1R43AR080477-01A1

Brad H Walker, OWL Cofounder and CEO stated, “We are very proud to receive this award. The OWL team’s diligence and tenacity was rewarded with an exceptionally high score on our grant application. On behalf of the OWL Leadership Team, a huge ‘Thank you!’ to our team and partners in making this a reality.”

Rajen N Shah, OWL Cofounder and President, concurred. “We are very grateful for the opportunity this grant provides us. This will allow us to further iterate our prototype toward a market-ready solution and conduct clinical trials where we will collect highly valuable data in partnership with our health care provider KOLs.”

Daniel L Paulsen, CFO and CIO, concurred while adding: “The NIH grant represents a valuable opportunity for OWL. It is non-dilutive and OWL will retain the IP generated from its application, both creating value for the shareholder and increasing wellness for our users, a win for all!”

Please contact us at hello@orthopedicwellnesslabs.com with any questions.